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Experimental study was performed on the possibility, that an intra-arterial infusion 
chemotherapy via the nutrient artery to malignant tumor inhibits the development of distant 
metastasis 
For this experiment Walker’s carcinosarcoma 256 implanted into the proximal tibia 
was used. For the purpose of intra-arterial infusion, a polyethylene catheter was inserted 
into the common iliac artery via contralateral femoral artery, through which chemotherapeutic 
agents, Mitomycin C (MC) and Cyclophosphamide (EX) were infused. 
398 rats were employed for this series. Among them, thirty-four rats which were 
not treated after tumor implantation were served as control. The tumor was taken in 
twenty-seven rats (79 4%). The mean survival period of the control series was 22. 5 
days Furthermore, pulmonary metastases have been noted grossly in 22 rats (64. 6) as 
eary as seventh day after implantation. 
364 tumor-bearing rats were treated in five separate ways・ (1) infusion chemotherapy 
of MC and EX with 50 units of heparin using intra-arterial catheterization by KLOPP’s 
procedure, (2) intra-arterial infusion of 50 units of heparin alone, (3) intravenous admini-
stration of MC and EX, ( 4)intraperitoneal administration of恥1Cand EX, and (5) above-
knee amputation after intra-arterial infusion chemotherapy. 
Intra-arterial infusion chemotherapy was started at four varing time intervals after 
implantation of the tumor mass into the proximal tibia (1) immediately after implanta-
tion, (2) at twenty-four hours, (3）山 toeight days, and (4) twelve to fourteen days. 
Administration of chemotherapeutic agents was performed once a day. The infusion was 
repeated for successive five days in al cases. High dosages （恥1C1. 0 mg/kg, and EX 
~4 号
;)()mg kg) and low dosages (MC 0. 1 mg/kg and EX 10 mg/kg) were given in each 
group of animals. In the other groups, systemic administration of MC and EX were per-
formed in the same way as that in intra-arterial infusion group. Intra-arterial infusion in 
154 rats out of 364 was performed, intravenous administration in 75, and intraperitoneal 
administration in 76. In 39 rats 50 units of heparin were given for five days as control. 
In 20 rats, the tumor-bearing hind limbs were amputated after intra-arterial infusion chemo-
therapy for five days was completed. 
In the group in which an intra-arterial infusion of anti-cancer agents was started im-
mediately after implantation, tumor growths in the tibia were observed in four rats (11.1%) 
out of 39, and pulmonary metastases were seen in two (5. 1%) of them. In the group 
in which an intra-arterial infusion of anti-tumor agents was started 24 hours after implan-
tation, tumor growths were observed in 15. 4%, and pulmonary metastatic ratio was 7. 7%. 
However, in the group in which an intra-arterial infusion was started at seven days 
or more after tumor implantation, primary tumor growths and pulmonary metastases were 
more frequently observed than in previous group. The results obtained were summerized 
in Table. 
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Table Observat旧nsat the time of death or日crifice( -1 I st day J after tumor implantatinn showmg 
1 A, rats apparently fre of tumor, I BI: rats with tumor of the tibia and without pulmonary me-
t出t.isis,and IC J rats with tumor of the tibia and pulmonary metastasis. 
brue: and Dos〕 Timei伽叫 of!No. ofT A：戸
1 /5 15~ [ administ. I rats ｜｜ υ｜ 
i within 2-1 h瓜 1・19 i 19：。 i0 
I 7 days町 mo町 I17 I 3 I 6 : s 
within 24 hrs. i 19 18 i 1 I 0 
7 days or more i 20 I 3 ] 6 I1 
m出 n24 h問 1 20 ! 1 I 1 I 2 
7 days or mo陀： 20 I 2 I .i ・ 1.i
WI仙 i2.J hrs. ! 20 i 14 ' 3 : 3 
, 7 days or mo町 I19 , 2 , 4 I 13
Heparin : within 24 h瓜： 20.7 5 8 
50 u./rat alone I 7 days or more I 19 i 1 5 13 
I with日 hrs. t 9 5 : 2 2 
7 days or mo日 i10 o• 416 
I within 24 h日： 10 7 ' I 2 






1. Intra-arterial infus10n 
MC O. lmg／ほ
EX 10田1g/kg








I within 2-1 hrs. 
7 days or more MC 0. lmg/kg 
?
? ??within己-1hrs. 
7 days or more 
within 2-1 hrs. 






within 2-i hrs. 5 




3. Amputation after intra-arterial infusion 
-1. C"ntn》l
制癌剤の局所動脈内挿管投与法の肺転移IC.及ぼす影響lζ闘する実験的研究 五（）日
The results obtained suggest that when an intra-arterial infusion chemotherapy is 
started within 24 hours after implantation, both of tumor take and pulmonary metastasis 
are markedly inhibited, and, when it is given seven days or more after implantation, lung 
metastasis is not prevented. 
Since heparin have no inhibitory effect on tumor-take and metastasis, it is evident 
that the inhibition of tumor growth in intra-arterial infusion chemotherapy was the effect 
of anti-cancer agent. 
Systemic administration of anti-tumor agents has some inhibitory effects on tumor 
growth and the development of metastasis, when it is performed at the early stage. 
There were no differences in the inhibitory effects between Mitomycin C and Cyclo-
phosphamide. 
In the group of intra-arterial infusion chemotherapy combined with amputation of 
tumor-bearing hind limb, no pulmonary metastasis was found in the earlier application 
group. But four rats out of six died of pulmonary metatasis in the group with later 
amputation. 
Pulmonary metastatic tumors were smallest in numb町 inthe group of intra-arterial 
infusion chemotherapy. 
Number and size distribution of pulmonary metastases are shown in Figs. 1 a through 
8. As seen in these Figures, tumors of small size are mostly cathegorized in number in 
the groups of early infusion, whereas tumors of large size are not rarely seen in the groups 
of later infusion. 
The facts suggest that anti-cancer agents make an attack on the “loose cancer cells" 
which are flowing in the blood stream or on the tumor cel emboli in the lung, prevent-













































悪い．悪性骨肉腫の5年生存率は14.9'.o ( 1il山. 1967 
























































いて Wistar系ラ ット皮下に累代移植されてきた Wal-

























































































mitomycin C （以下 MCと略す）の2種類で，その各
々の高濃度欝 CEX50mg/kg. MC l.Oaig/kg）及び低濃
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I 1移 植｜ I ID市転移川J l'.J ！動物数留物装｜詰物語審物愛思~~~.~ : 
直後投与群：io 1 I s , 2 I • : 23. 2 
早期投与群l 10 6 i 9 ! I I 4 I 21. ~ 
中期投与剖 10 . 9 I 10 I 0 : 6 I 21.5 
晩期投与問 9 : 9 j 9 i O i 7 I 19. 7 
















































定による信頼限界は ~I:!. 4%～“」 9°0( p三五005）と
更に高率となる．刷i転移巣は肺表面の殆ど全域lζ互る
高度のものから，数業lζ限局するものまで種々である
か， 平均脈転移巣数は 31.6個／ratであった 又肺転












Wall司r 腰湯を右~骨骨髄内lこ移植 し， 5 分後lζ尾静
脈より MC及びEXのよ：j濃度又は低濃度を注射された






と．危険率s~，；において，直後静注群の P は7. 19,
早期静注群のがは5.32となり，いずれも有意の差が
あるといえる結果を得た．しかし， 1=j1期静注群では肺
転移率は19頭中 ti~~ I l:!. 0%・1, I 1'~ ＝：！.日4. P三0.05)




l動脈型国師肉！随肢内l一一＿＿］；＿~駐竺唾~m最後二iロ川／匂l a i rs I rs1-=-
握1Ex10 1~.o i 22 1 21 ！一
号IMC 1.0 I 0 : 15 : 20 i 0 
訴IMC 0. 1 i 9 i 18. 5 I 22. 5 I 0 
｜ヘバリン I2r. 2 i一 一 ｜
t EX 50 i 0 I 21 16 
号！EX 1 O : 8 i 20 I 23. 5 
望！MC 1.0 I 0 I 20 : 17. 5 
量： MC 0. 1 1 10 i 19 I 25. o 
刊｜へパリン i 26. 5 1 i 
i 12. s I幻 I17. 0 I 
I 14.0 I 28 I 19.0 
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きなかった（表 1) • これに対し移植直後のへパリン












































r:j~期静脈内投与群では， 19頭中 H 頭（42.0%）の肺転



























































































































































































































































果の一つの指標となる．また Collins13>14＞が指摘する た．即ち，直径 1mm以下をII＇之， 1mm以上2mm以下を
ように，もし腫揚が一定の発育速度で増殖し続けるも I i'l. :! mm以上3mm以下をmi吃， 3 mm以上5mm以下を
のとすれIt,lri転移結節の大きさから転移発生の時点 IV l'l', 5阻以＿Lx皿以下をい＇i.x mm以上を＼T度とし
表7 制癌剤動脈内挿管投与後切断群における肺転移率
！国営uJ物数 1 事故死数｜有効吋生存日数同~lffi転移率
MC 1.0 I 3 I 1 ! 2 I 』lト I o I o 




5 3 H ' 33.3 
-I ' 
:!-I d. 
晩期投与後切断群 5 2 3 コ7d. 3 100 
:l5 d. 
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Il Il IV ¥ ¥I 
図3a 中期動脈内挿管投与群nm転移巣の大きさ
と数





トー－ EX 50mg/kg 
0---一一喧 EX 10 /1 
t 一一色 MC 1.0 II 
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r E 皿 IV ＼羽
図6 制痛剤投与ルート別町i転移巣の大きさと数
MC 0.lmg/kg，早期投与
・ーーーー『・ l. a. 
。---0 l. v . 
..＿＿‘ I p. 




































































































































図18 中期 MC0. Jmg’kg動脈内5日間投＇ j..核
の 11~；fヒ，向肢の消’人，クロ 7チンの不鮮明
化， T京仁（/_Ji／；＇）相同通みられる． ×1 IX)!) 




1w； 化 ， 核l民およびクロマチンの消 F人． 核［！~

















































































1'1, Grady (1953)24', Sullivan (1953)67）らによって同
様の報告がなされた．



























割投与法から長期持続投与法に移り， 111fu,ion pump 



















































































































































































最大のものは 1mmの径を有し， 22日目では， 8mm～10 
mであった.Collinsの仮設に従って，細胞増殖速度は
一定であり，転移巣が径10μの単一腫場細胞から発生
したものとすれば， 1 mm径の転移結節は 20doublings 
を経て成長したことになる． まだ 1cm径のものは 30
doublingsを経たものという計算になる．一方 Walker





































































































































































































祖rcoma~：）ti の組織細片を移植し，左大腿動脈より大 吾を戴いた病理学教室浜島義博助教授に （'f刈代しま
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